Cleared Traditional

K862355 - TRANS-PULSE MODEL #1103

K862355 is an FDA 510(k) clearance for TRANS-PULSE MODEL #1103, manufactured by The Sun Co.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 57-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1986
Decision
57d
Days
Class 2
Risk

K862355 is an FDA 510(k) clearance for the TRANS-PULSE MODEL #1103. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by The Sun Co. (Tampa, US). The FDA issued a Cleared decision on August 19, 1986 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K862355

510(k) Number K862355 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 1986
Decision Date August 19, 1986
Days to Decision 57 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
92d faster than avg
Panel avg: 149d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K862355.
AGAR 9K TENS
K861894 · Solcoor, Inc. · Sep 1986
UNI-TENS
K861895 · Solcoor, Inc. · Sep 1986
UNI-TENS XL TENS
K861896 · Solcoor, Inc. · Sep 1986
ULTRAPAC II SD (TM)
K862337 · Medical Devices, Inc. · Aug 1986
WALLANT NEUROLOGIX DUAL PUR NERVE/NEUROMUSCU STIMU
K861119 · Wallant Intl. Trade, Inc. · Aug 1986
WALLANT NEUROLOGIX GENERAL PURPOSE TENS
K860847 · Wallant Intl. Trade, Inc. · Aug 1986